Background: The placenta is a central focus and important in the pathogenesis of
preeclampsia occurrence. Failure of trophoblast cells do remodeling spiral arteries
due to excessive apoptosis causes uteroplacental ischemia and damage the
endothelial cells that give rise to the clinical manifestations of preeclampsia.
Excessive apoptosis in preeclampsia occurs through the intrinsic pathway of
apoptosis mediated intracellular where directly from mitochondria in response to
stress such as mitochondrial damage and can be activated by
p53, a protein that activates the tumor suppressive action of Bcl-2 proapoptotic.
Extrinsic and intrinsic pathways are not independent, because p53 can also
enhance the expression of several death receptors.
Objective: To compare the expression of p53 protein on pregnancy trophoblast
between severe preeclampsia complicated pregnancy and normotension
pregnancy.
Methods of study: This study is a cross-sectional design of the study population
of patients with severe preeclampsia 2011 to March 2012. Placental samples
obtained from 43 pregnancies with severe preeclampsia and 38 normotensive
placentas from pregnancies. Observation of P53 protein expression by
immunohistochemistry technique. Statistical analysis using independent t<0.05)..32 ± 0.18).
Results: There were significant differences (p = 0.00) p53 protein expression in
the gestational trophoblastic tissue severe preeclampsia (1.99 ± 0.66) compared to
the normotensive pregnancies (1
Conclusion: Expression of p53 protein in severe preeclampsia is higher than
normotensive pregnancies